Benchmark raised the firm’s price target on LiveRamp to $35 from $33 and keeps a Buy rating on the shares ahead of the company’s fiscal Q1 report due on Wednesday, August 9. The firm’s conversation with management in July left it “incrementally bullish” regarding sustained fixed opex leverage, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAMP: